Your browser doesn't support javascript.
loading
Bisphosphonates and bisphosphonate induced osteonecrosis.
Sawatari, Yoh; Marx, Robert E.
Afiliação
  • Sawatari Y; Division of Oral and Maxillofacial Surgery, University of Miller Miami School of Medicine, 9380 SW 150th Street, Miami, FL 33157, USA. ysawatari@med.miami.edu
Oral Maxillofac Surg Clin North Am ; 19(4): 487-98, v-vi, 2007 Nov.
Article em En | MEDLINE | ID: mdl-18088900
ABSTRACT
Bisphosphonate-induced osteonecrosis of the jaws is the correct term for this real drug complication that most dental practitioners face. All nitrogen-containing bisphosphonates pose a risk, which is related to the route of administration, the potency of the bisphosphonate, and the duration of use. Although intravenous bisphosphonate-induced osteonecrosis of the jaws is mostly permanent, most cases can be prevented or managed if they develop, with only a few cases requiring resection for resolution. Oral bisphosphonate-induced osteonecrosis of the jaws also can be prevented with knowledge of the risk level related to the duration of use and the C-terminal telopeptide blood test results. Most cases can be resolved with a drug holiday either spontaneously or via straightforward débridement.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteonecrose / Doenças Maxilomandibulares / Difosfonatos / Conservadores da Densidade Óssea Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteonecrose / Doenças Maxilomandibulares / Difosfonatos / Conservadores da Densidade Óssea Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article